Novartis Sponsored Heart Failure Symposia at Heart Failure 2017 & 4th World Congress on Acute Heart Failure

Please note this content is not intended for
healthcare professionals licensed in the USA

Novartis Sponsored Heart Failure Symposia at Heart Failure 2017 & 4th World Congress on Acute Heart Failure

Video On Demand

Contemporary management of patients with HFrEF

12:45 - 14:00 CEST Sunday 30th April 2017
Hugo Room, Le Palais des Congrès de Paris

Chairs: Faiez Zannad (France) and John McMurray (UK)

  Topic Faculty
12:45–12:48 Welcome and introduction Faiez Zannad (France) and
John McMurray (UK)
12:48–12:58 One year after updating the heart failure guidelines – has the management of patients with HFrEF changed? John McMurray (UK)
12:58–13:28 Managing contemporary HFrEF therapies – clinical case discussion Peter van der Meer (The Netherlands)
13:28–13:58 Optimising contemporary HFrEF therapies in patients with comorbidities – clinical case discussion Frank Ruschitzka (Switzerland)
13:58–14:00 Summary and key learning points Faiez Zannad (France)

The learning objectives for this open forum expert discussion focused on:

  • Understand how the latest guidelines and clinical evidence impact clinical practice in the treatment of heart failure with reduced ejection fraction
  • Understand the use of evidence-based treatments in different patient types with heart failure with reduced ejection fraction
  • Appreciate the importance of patient follow-up to ensure optimal treatment management to achieve improved care
  • Cardiologists
  • Heart Failure Specialists

 

Novartis sponsored satellite symposium at Heart Failure 2017 & 4th World Congress on Acute Failure
©2017 Novartis Pharma AG, CH-4002 Basel – March 2017 – GLCM/HTF/0408

 

 

 

 

 

Optimising treatment of heart failure – where are we today?

This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC Heart Failure 2017. Watch this video recording to hear the questions and discussions from this interactive 30 minute session.

The learning objectives for this open forum expert discussion focused on:

  • How emerging key data supporting a variety of novel therapies under evaluation in acute heart failure (AHF) may help to address unmet treatment needs in acute heart failure (AHF)
  • How to manage contemporary treatments in heart failure with reduced ejection fraction (HFrEF)

 

Novartis sponsored satellite symposium at Heart Failure 2017 & 4th World Congress on Acute Failure
©2017 Novartis Pharma AG, CH-4002 Basel – March 2017 – GLCM/HTF/0408